BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ruuska T, Küster P, Grahnquist L, Lindgren F, Wewer AV. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis. World J Gastroenterol 2016; 22(17): 4389-4396 [PMID: 27158208 DOI: 10.3748/wjg.v22.i17.4389]
URL: https://www.wjgnet.com/1007-9327/full/v22/i17/4389.htm
Number Citing Articles
1
Filippo Vernia, Angelo Viscido, Giovanni Latella. Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisitedJournal of Clinical Apheresis 2023; 38(6): 746 doi: 10.1002/jca.22091
2
J.L. Cabriada, I. Rodríguez-Lago. Granulocitoaféresis en 2017. Puesta al díaEnfermedad Inflamatoria Intestinal al Día 2017; 16(2): 62 doi: 10.1016/j.eii.2016.12.001
3
Rafael Martín-Masot, Pilar Ortiz Pérez, Encarnación Torcuato Rubio, Javier Blasco Alonso, Marta Herrador López, Carmen Gallego Fernández, Víctor Manuel Navas-López. The New Molecules Are Changing the Course of Pediatric Chronically Active Ulcerative Colitis: A Series of Pediatric CasesJPGN Reports 2021; 2(3): e100 doi: 10.1097/PG9.0000000000000100
4
Helena Rolandsdotter, Michael Eberhardson, Ulrika L. Fagerberg, Yigael Finkel. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New‐Onset Inflammatory Bowel ColitisJournal of Pediatric Gastroenterology and Nutrition 2018; 66(1): 84 doi: 10.1097/MPG.0000000000001641
5
Daniel Vasile Balaban, Mariana Jinga. Crohn’s Disease Recent Advances2021;  doi: 10.5772/intechopen.93605
6
Satoshi Motoya, Hiroki Tanaka, Tomoyoshi Shibuya, Taro Osada, Takayuki Yamamoto, Hitoshi Hongo, Chiemi Mizuno, Daisuke Saito, Nobuo Aoyama, Toshihisa Kobayashi, Hiroaki Ito, Satoshi Tanida, Masanori Nojima, Seiichiro Kokuma, Eiji Hosoi. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort studyBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1110-1
7
Tomotaka Tanaka. Therapeutic Granulomonocytapheresis as a Non-pharmacologic Treatment Option for Inflammatory Bowel Disease: Efficacy Reports on a Wide Age Range and Disease ProfileCureus 2023;  doi: 10.7759/cureus.48913
8
Tomotaka Tanaka, Takayuki Yamamoto, Koji Sawada, Rodolfo Sacco. Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Expert Review of Gastroenterology & Hepatology 2017; 11(8): 749 doi: 10.1080/17474124.2017.1341309
9
Y. Koike, M. Okubo, T. Kiyohara, R. Fukuchi, Y. Sato, S. Kuwatsuka, T. Takeichi, M. Akiyama, K. Sugiura, A. Utani. Granulocyte and monocyte apheresis can control juvenile generalized pustular psoriasis with mutation ofIL36RNBritish Journal of Dermatology 2017; 177(6): 1732 doi: 10.1111/bjd.15509